Researchers at the University of California, Los Angeles (UCLA) have shown that boosting the activity of a healthy copy of a gene can partially compensate for the effects of autism-linked mutations. The findings were published in the journal Nature Neuroscience. So far, the method has only been tested in laboratory-grown models of human brain cells.

Many genetic mutations associated with neurodevelopmental disorders disrupt the function of one of the two copies of a particular gene. The remaining healthy copy is often insufficient for normal cell function. Most existing autism treatments focus on alleviating symptoms rather than addressing these underlying biological disruptions.

A team led by Daniel Geschwind studied two autism-linked genes: CHD8 and SCN2A. The first helps regulate genes needed for brain development, while the second plays an important role in transmitting electrical signals between neurons.

The scientists used a modified CRISPR technology to increase the activity of the healthy gene copy without editing the gene itself. To do this, they targeted regions of DNA that regulate its activity, aiming to preserve the process's natural controls.

In models with a CHD8 mutation, the intervention reduced the abnormal overgrowth of organoids—small cellular structures that replicate some features of the developing brain—and promoted cell maturation. In models with an SCN2A mutation, the researchers were able to largely restore normal electrical activity in neurons.

The effect was observed in cell models carrying the corresponding mutations, while healthy cells showed no increase in gene activity. The results also depended on the cell type and the timing of the intervention.

The authors emphasize that the method is still a long way from use in humans. A safe way to deliver the technology to the brain must be developed, and researchers need to determine whether it can be effective after the early stages of development have ended. Nevertheless, the study points to a potential approach to treating genetic neurodevelopmental disorders: rather than correcting the damaged copy of a gene, it may be possible to boost the activity of the healthy one.